ARID4B and metabolic syndrome: In line with our expectations, the serum valine, leucine, and isoleucine levels exhibited a significant reduction in HFD-mice that were treated with CO compared to that of amino acids in the HFD group (p < 0.001), which suggested that the anti-dyslipidemia effect of CO may be closely associated with the serum BCAA concentration (Figure 2A).